SYNOPSIS: IRCTC will be phased out of the F&O segment under revised SEBI norms, with no new contracts issued. Existing derivative contracts will continue trading until their respective expiries by February 2026. Shares of a Navratna PSU and the only company...
Synopsis:- The regulatory signals on allowing banks and insurers into commodity derivatives boosted growth expectations. Strong Q2 performance, with 30% revenue growth, 28% profit rise, and sharp increases in futures (55%) and options (91%) trading volumes further...
Synopsis:- The board approval to amalgamate the holding company into the listed entity, simplifying the structure. The impact on investors is limited, with promoter stake rising marginally from 72.17% to 72.20%. Additional shares are issued at Rs 375, above market...
Synopsis: Hitachi Energy India Ltd shows strong financial momentum with FY23–FY25 revenues rising from Rs. 4,469 cr to Rs. 6,385 cr, net profit surging from Rs. 94 cr to Rs. 384 cr, and a record order backlog of Rs. 29,412.6 cr, supporting justified valuations. The...
Reinsurance plays a critical role in the insurance ecosystem by enabling effective risk transfer and supporting the stability and growth of the insurance industry. In a typical reinsurance framework, policyholders transfer individual risks – such as motor, property,...
Synopsis: The share of the company was up 12 percent after 91 acres of land monetisation news came, with an estimated value of Rs. 3,473 crore for paying off dues, for which the reply is awaited. The shares of this company engaged in manufacturing, trading and...
SYNOPSIS: NBCC (India) secured a Rs. 179.37 crore project from IIM Sambalpur to provide project management consultancy services for Phase-II infrastructure development of its permanent campus. During Friday’s trading session, shares of a Government of India Navratna...
Synopsis: One 97 Communications jumped sharply after the RBI gave a green signal to PPSL, its subsidiary, to function as a Payment Aggregator for offline and cross-border transactions, apart from the online licence The shares of this leading fintech company are in...
Synopsis:- Shares jumped up to 3% after securing a Letter of Award for refurbishing a 2×500 MW HVDC project. Strong order wins, a ₹131.1 billion backlog, 39% revenue growth, and planned ₹8,060 million capex further strengthened investor confidence despite short-term...
Synopsis: Glenmark Pharmaceuticals Limited has secured exclusive multi-regional rights for Aumolertinib from Hansoh Pharma, strengthening its oncology portfolio with a globally approved third-generation EGFR-TKI for treating EGFR-mutated non-small cell lung cancer....
